Epithelial-mesenchymal transitions in tumour progression | Nature Reviews Cancer | 2002 | 5.2K |
The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Nature Reviews Cancer | 2002 | 4.9K |
New functions for the matrix metalloproteinases in cancer progression | Nature Reviews Cancer | 2002 | 4.8K |
Multidrug resistance in cancer: role of ATP-dependent transporters | Nature Reviews Cancer | 2002 | 4.3K |
Hypoxia--a key regulatory factor in tumour growth | Nature Reviews Cancer | 2002 | 4K |
The Bcl2 family: regulators of the cellular life-or-death switch | Nature Reviews Cancer | 2002 | 3.1K |
Dissemination and growth of cancer cells in metastatic sites | Nature Reviews Cancer | 2002 | 3K |
Papillomaviruses and cancer: from basic studies to clinical application | Nature Reviews Cancer | 2002 | 2.9K |
Live or let die: the cell's response to p53 | Nature Reviews Cancer | 2002 | 2.6K |
Cancer statistics, 2002 | Ca-A Cancer Journal for Clinicians | 2002 | 2.3K |
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer | Journal of Clinical Oncology | 2002 | 2.2K |
Metastasis to bone: causes, consequences and therapeutic opportunities | Nature Reviews Cancer | 2002 | 2.2K |
NF-kappaB in cancer: from innocent bystander to major culprit | Nature Reviews Cancer | 2002 | 2.1K |
Role of angiogenesis in tumor growth and metastasis | Seminars in Oncology | 2002 | 1.9K |
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Experimental Hematology | 2002 | 1.9K |
Gene expression correlates of clinical prostate cancer behavior | Cancer Cell | 2002 | 1.8K |
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer | Journal of Clinical Oncology | 2002 | 1.7K |
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Journal of Clinical Oncology | 2002 | 1.6K |
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols | Journal of Clinical Oncology | 2002 | 1.5K |
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling | Cancer Cell | 2002 | 1.5K |
Death and anti-death: tumour resistance to apoptosis | Nature Reviews Cancer | 2002 | 1.5K |
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B | Journal of Clinical Oncology | 2002 | 1.5K |
Role of integrins in cell invasion and migration | Nature Reviews Cancer | 2002 | 1.4K |
Hyperthermia in combined treatment of cancer | Lancet Oncology, The | 2002 | 1.4K |
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia | Cancer Cell | 2002 | 1.4K |